POWERED BY BIOHM

Serial Number 87757230
Registration 6707595
700

Registration Progress

Application Filed
Jan 16, 2018
Under Examination
Feb 19, 2019
Approved for Publication
Dec 25, 2018
Published for Opposition
Dec 25, 2018
Registered
Apr 19, 2022

Trademark Image

POWERED BY BIOHM

Basic Information

Serial Number
87757230
Registration Number
6707595
Filing Date
January 16, 2018
Registration Date
April 19, 2022
Published for Opposition
December 25, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 19, 2022
Registration
Registered
Classes
001 005

Rights Holder

BIOHM HEALTH INC.

99
Address
425 LITERARY ROAD
SUITE 100
CLEVELAND, OH 44113

Ownership History

PathoBiome LLC

Original Applicant
16
Cleveland, OH

PathoBiome LLC

Owner at Publication
16
Cleveland, OH

BIOHM HEALTH LLC

New Owner After Publication #1
16
CLEVELAND, OH

BIOHM HEALTH LLC

Original Registrant
16
CLEVELAND, OH

BIOHM HEALTH INC.

New Owner After Registration #1
99
CLEVELAND, OH

Legal Representation

Attorney
Lisa C. Pavento

USPTO Deadlines

Next Deadline
817 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220419)
Due Date
April 19, 2028
Grace Period Ends
October 19, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Oct 21, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 21, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 21, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 15, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 19, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 15, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 13, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 1, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 18, 2022 IUAF S USE AMENDMENT FILED Loading...
Feb 18, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 10, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 9, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 28, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 6, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 28, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 17, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 15, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 15, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 15, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 5, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 5, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 5, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 5, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 5, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 21, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 19, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 19, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 19, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 28, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 27, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 18, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 27, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 18, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 18, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 20, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 16, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 16, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 19, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 30, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 25, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 25, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 5, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 12, 2018 ALIE A ASSIGNED TO LIE Loading...
Oct 28, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 26, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 26, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 26, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 30, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 30, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...

Detailed Classifications

Class 001
Food products containing probiotic compositions, namely, probiotic bacteria and probiotic bacterial cultures for use as a food additive for food manufacturing; human food products containing probiotic compositions, namely, probiotic bacteria and probiotic bacterial cultures for use as a food additive for food manufacturing; animal food products containing probiotic compositions, namely, nutritional additives for use in manufacturing animal feed
First Use Anywhere: Feb 17, 2022
First Use in Commerce: Feb 17, 2022
Class 005
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; beverages containing probiotic compositions for use as a nutritional supplement; food supplements containing probiotic compositions; human food supplements products containing probiotic compositions; animal food products containing probiotic compositions, namely, probiotic animal feed; dietary supplement drink mixes, namely, probiotic compositions in the form of mixes to added to beverages; dietary supplements in the nature of probiotic compositions for mixing with cereal
First Use Anywhere: Feb 17, 2022
First Use in Commerce: Feb 17, 2022

Classification

International Classes
001 005